Related Experiment Video
Updated: Apr 28, 2026
06:41
In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
12.4K
RAREMETAL: fast and powerful meta-analysis for rare variants
Shuang Feng1, Dajiang Liu1, Xiaowei Zhan1
1Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, MI 48109, USA.
Bioinformatics (Oxford, England)
|June 5, 2014
Summary
RAREMETAL is a powerful tool for analyzing rare genetic variants in large studies. It efficiently performs meta-analyses, accommodating diverse data and complex genetic structures for comprehensive insights.
Area of Science:
- Genetics
- Bioinformatics
- Statistical Genetics
Background:
- Rare genetic variants play a crucial role in complex diseases.
- Accurate meta-analysis of rare variants is essential for robust genetic association studies.
- Existing tools may lack efficiency or flexibility for diverse genomic data.
Purpose of the Study:
- To introduce RAREMETAL, a novel computational tool for rare variant meta-analysis.
- To provide a flexible and efficient platform for analyzing rare variants from sequencing and array data.
- To enable comprehensive genetic association analyses, including single variant and burden tests.
Main Methods:
- RAREMETAL is a computationally efficient software tool.
- It supports various input file formats for genetic data.
- The tool handles both related and unrelated individuals in analyses.
Main Results:
- RAREMETAL facilitates individual study analyses.
- It executes single variant and burden tests.
- Conditional association analyses are also performed.
Conclusions:
- RAREMETAL is an efficient tool for rare variant meta-analysis.
- It accommodates diverse genotyping data (sequencing, arrays) and population structures.
- The tool supports a wide range of association analyses for genetic discovery.
More Related Videos
Related Concept Videos
01:05Single Nucleotide Polymorphisms-SNPs
14.5K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
14.5K
01:27Principles of Pharmacogenetics: Types of Genetic Variants
137
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
137
02:26Comparing Copy Number Variations and SNPs
11.6K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
11.6K
01:11Genome-wide Association Studies-GWAS
12.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.6K
01:29Pharmacogenomics: Identification of New Drug Targets
119
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
119